glargine

Key facts

Mechanism of action

Insulin receptor agonist

Primary target: Insulin receptor

Approval history

1. Glargine Phase 3 · Eli Lilly and · Diabetes Mellitus, Type 2
2. Insulin glargine/Lixisenatide (HOE901/AVE0010) Phase 3 · Sanofi Pasteur MSD · Type 2 Diabetes Mellitus
3. J2A-MC-GZGW Phase 3 · Eli Lilly and · Type 2 Diabetes
4. NN9388-7637 Phase 3 · NovoThirteen · Type 2 diabetes
5. albiglutide + insulin glargine Phase 3 · GSK Glaxo Smith · Diabetes Mellitus, Type 2
6. BioPhenoT2D Approved · Telethon Foundation · type 2 diabetes
7. INSULIN GLARGINE Approved · Sanofi-Aventis U.S · Diabetes mellitus II
8. INSULIN GLARGINE (HOE901) Approved · Sanofi Pasteur MSD · Diabetes Mellitus, Type 2

1. insulin aspart Alimentary tract and metabolism (A10)
2. insulin aspart protamine recombinant Insulin receptor agonist
3. insulin aspart recombinant Insulin receptor agonist
4. insulin degludec Alimentary tract and metabolism (A10)
5. insulin detemir Alimentary tract and metabolism (A10)
6. insulin detemir recombinant Insulin receptor agonist

Frequently asked questions